2015
DOI: 10.1007/s12015-015-9593-9
|View full text |Cite
|
Sign up to set email alerts
|

Tissue Engineering: New Tools for Old Problems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 28 publications
0
5
0
Order By: Relevance
“…Unfortunately, the demand largely overcomes the availability, as just 31,768 organs were received in the same year, causing the daily death of around 20 people waiting for an organ [1]. Tissue Engineering and Regenerative Medicine (TERM) strategies are seen as promising approaches to solve the issue of organ shortage [2]. However, limitations of traditional TERM strategies such as low anchorage to the desired site in the case of cell injection [3], strong host reaction in response to the biodegradation of the scaffolds [4], or insufficient delivery of oxygen and nutrients to the bulk of scaffolds, are precluding their widespread clinical application.…”
Section: Introductionmentioning
confidence: 99%
“…Unfortunately, the demand largely overcomes the availability, as just 31,768 organs were received in the same year, causing the daily death of around 20 people waiting for an organ [1]. Tissue Engineering and Regenerative Medicine (TERM) strategies are seen as promising approaches to solve the issue of organ shortage [2]. However, limitations of traditional TERM strategies such as low anchorage to the desired site in the case of cell injection [3], strong host reaction in response to the biodegradation of the scaffolds [4], or insufficient delivery of oxygen and nutrients to the bulk of scaffolds, are precluding their widespread clinical application.…”
Section: Introductionmentioning
confidence: 99%
“…Heart transplantation procedures represented an expense of approximately 134 million euros in 2019 ( 2 ), while donation and transplantation of blood, tissues, and cells are estimated to represent around 6 billion euros per year in the EU alone ( 3 ). Tissue engineering and regenerative medicine (TERM) represent potential solutions to this problem and have therefore been attracting increased interest from clinicians ( 4 ). Tissue engineering approaches, in particular, typically use bioartificial 3D matrices termed scaffolds, composed of the most diverse materials, where cells are seeded and allowed to grow, to yield the desired tissue-like constructs.…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies have revealed that as a major component of multicellular organisms, extracellular matrix (ECM) not only provides necessary mechanical and adhesive support to the cells, but also regulates various cell behaviors through facilitating the transmission of biochemical cues [1][2][3][4][5][6]. Systematic investigations on the interactions between the cell behaviors and its ECM can not only improve our understandings on the mechanisms underlying intricate cellular activities, but also contribute to the development of tissue engineering strategies for effective cell therapies [7][8][9][10][11][12][13]. Despite the vast advancement made in in-vivo studies, due to the complex and dynamic nature of physiological environment, in-vitro approaches are still widely applied in exploring some complex interplay between cells and their ECM, where cells are cultured and perturbed in bio-mimic scaffolds that are highly recapitulating their physiological microenvironment yet remain great flexibility in manipulatable components to decouple the entangled factors.…”
Section: Introductionmentioning
confidence: 99%